{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:12:32Z","timestamp":1792613552519,"version":"4.5.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> The clinical characteristics of patients with PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection) and PANS (pediatric acute-onset neuropsychiatric syndrome) and the efficacy of antibiotic therapy with psychotherapy and antipsychotics were investigated to improve neurological symptoms as well as obsessive compulsive disorder (OCD).<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We retrospectively analyzed 62 patients with a clinical diagnosis of PANDAS\/PANS enrolled from May 14, 2013 to September 15, 2020 in the Neurology Childhood Division, Department of Pediatrics at Sapienza, Rome. Clinical manifestations, neurological and psychiatric, laboratory investigations, and familiar history were collected to evaluate the differences between the two groups. The effects of various therapeutic approaches were examined. Descriptive and comparative statistical analyses were performed.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The mean age at onset of PANDAS\/PANS symptoms was 6.2 \u00b1 1.2 years. The most common diagnosis was PANDAS, followed by PANS. Neurological and psychiatric symptoms were mostly evident in both groups (&amp;gt;70% of the population), with no significant difference between them (<jats:italic>P<\/jats:italic> = 0.52 and <jats:italic>P<\/jats:italic> = 0.15, respectively). Irritability, aggressivity, and food restriction were more prevalent in children with PANS than in those with PANDAS (<jats:italic>P<\/jats:italic> = 0.024 and <jats:italic>P<\/jats:italic> = 0.0023, respectively). The levels of anti-streptolysin O and anti-DNAse B 10-fold higher in PANDAS than those in PANS (<jats:italic>P<\/jats:italic> &amp;lt; 0.0001). Antibiotics or psychotherapy were administered in most cases (90.3 and 53.2%, respectively), followed by antipsychotic treatments (24.2%). In the multivariate analysis, among the therapies used, psychotherapy significantly resulted in the most efficacious relief of OCD, reducing stress in patients and their parents (<jats:italic>P<\/jats:italic> = 0.042).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Our findings confirm a clear clinical difference between the two groups, PANDAS and PANS, using different approaches. In fact, irritability, aggressivity, and food restriction were significantly more frequent in children with PANS and the levels of anti-streptolysin O and anti-DNAse B were higher in PANDAS. Another relevant finding is the efficacy of psychotherapy, especially for obsessive-compulsive disorder, and of antibiotic prophylaxis in managing acute neurological symptoms.<\/jats:p>","DOI":"10.3389\/fneur.2021.741176","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T04:34:13Z","timestamp":1632803653000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Clinical Features in Patients With PANDAS\/PANS and Therapeutic Approaches: A Retrospective Study"],"prefix":"10.3389","volume":"12","author":[{"given":"Isabella","family":"Rea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana Alessia","family":"Guido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Spalice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1176\/ajp.155.2.264","article-title":"Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases","volume":"155","author":"Swedo","year":"1998","journal-title":"Am J Psychiatry."},{"key":"B2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jaac.2010.10.011","article-title":"Streptococcal upper respiratory tract infections and exacerbations of tic and obsessive-compulsive symptoms: a prospective longitudinal study","volume":"50","author":"Leckman","year":"2011","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4172\/2161-0665.1000113","article-title":"From research subgroup to clinical syndrome: modifying the PANDAS criteria to describe PANS (pediatric acute-onset neuropsychiatric syndrome)","volume":"2","author":"Swedo","year":"2012","journal-title":"Pediatr Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1089\/cap.2014.0081","article-title":"Multidsciplinary clinic dedicated to treating youth and pediatric acute-onset neuropsychiatric syndrome: presenting characteristics of the first 47 consecutive patients","volume":"25","author":"Frankovich","year":"2015","journal-title":"J Child Adolesc Psychopharmacol."},{"key":"B5","article-title":"Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS)","volume-title":"Streptococcus pyogenes: Basic Biology to Clinical Manifestation","author":"Orefici","year":"2016"},{"key":"B6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1089\/cap.2016.0151","article-title":"Clinical management of pediatric acute-onset neuropsychiatric syndrome part III-treatment and prevention of infections","volume":"27","author":"Cooperstock","year":"2017","journal-title":"J Child Adoles Psychopharmacol."},{"key":"B7","first-page":"893","article-title":"Post-streptococcal autoimmune sequelae: rheumatic fever and beyond","volume-title":"Streptococcus pyogenes: Basic Biology to Clinical Manifestations","author":"Cunningham","year":"2016"},{"key":"B8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1176\/appi.ajp.2020.19070698","article-title":"Antibodies from children with PANDAS bind specifically to striatal cholinergic interneurons and alter their activity","volume":"178","author":"Xu","year":"2021","journal-title":"Am J Psychiatry."},{"key":"B9","doi-asserted-by":"publisher","first-page":"562","DOI":"10.189\/cap.2017.0042","article-title":"Overview of treatment of pediatric acute-onset neuropsychiatric syndrome","volume":"27","author":"Swedo","year":"2017","journal-title":"J Child Adolesc Psychopharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","article-title":"The yale global tic severity scale: initianl testing of a clinician-rated scale of tic severity","volume":"28","author":"Leckman","year":"1989","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"key":"B11","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1097\/00004583-199706000-00023","article-title":"Children's yale-brown obsessive compulsive scale: reliability and validity","volume":"36","author":"Scahill","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"key":"B12","first-page":"39","article-title":"The multidimensional anxiety scale for children (MASC)","volume-title":"The Use of Psychological Testing for Treatment Planning and Outcomes Assessment: Instruments for Children and Adolescents","author":"March","year":"2004"},{"key":"B13","volume-title":"Wechsler Intelligence Scale for Children-Fourth Edition: Canadian (WISC-IV)","author":"Wechsler","year":"2005"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/cap.2014.0084","article-title":"Clinical evaluation of youth with pediatric acute onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS Consensus Conference","volume":"25","author":"Chang","year":"2014","journal-title":"J Child Psychoprmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jneuroim.2017.09.002","article-title":"Biomarkers for diagnosis of pediatric acute neuropsychiatric syndrome (PANS)-sensitivity and specificity of the Cunningham panel","volume":"312","author":"Hesselmark","year":"2017","journal-title":"J Neuroimmunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1089\/cap.2014.0010","article-title":"Cefdinir for recent-onset pediatric neuropsychiatric disorders: a pilot randomized trial","volume":"25","author":"Murphy","year":"2015","journal-title":"J Child Adolesc Psychopharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.bbi.2017.12.004","article-title":"Differential binding of antibodies in PANDAS patients to cholinergic interneurons in the striatum","volume":"69","author":"Frick","year":"2017","journal-title":"Brain Behav Immun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jpsychires.2018.11.013","article-title":"Psychotic symptoms in youth with pediatric aute-onset neuropsychiatric syndrome (PANS) may reflect syndrome severity and heterogeneity","volume":"110","author":"Silverman","year":"2019","journal-title":"J Psychiatr Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1177\/0883073814543303","article-title":"Evaluation of basal ganglia and thalamic inflammation in children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection and Tourette syndrome: a positron emission tomographic (PET) study using 11C-[R]-PK-11195","volume":"30","author":"Kumar","year":"2015","journal-title":"J Child Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e204063","DOI":"10.1001\/jamanetworkopen.2020.4063","article-title":"Association of pediatric acute-onset neuropsychiatric syndrome with microstructural differences in brain regions detected via diffusion-weighted magnetic resonance imaging","volume":"3","author":"Zheng","year":"2020","journal-title":"JAMA Netw Open."},{"key":"B21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/s0022-3999(02)00582-2","article-title":"PANDAS a commentary","volume":"55","author":"Singer","year":"2003","journal-title":"J Psychosom Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"645267","DOI":"10.3389\/fnins.2021.645267","article-title":"Metabolomic characterization of pediatric acute-onset neuropsychiatric syndrome (PANS)","volume":"15","author":"Murgia","year":"2021","journal-title":"Front Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jneuroim.2010.08.017","article-title":"Maternal history of autoimmune disease in children presenting with tics and\/or obsessive\u2013compulsive disorder","volume":"229","author":"Murphy","year":"2010","journal-title":"J Neuroimmunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1097\/00004583-200009000-00011","article-title":"Psychiatric disorders in first-degree relatives of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS)","volume":"39","author":"Lougee","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"key":"B25","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.biopsych.2004.12.035","article-title":"Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders","volume":"57","author":"Snider","year":"2005","journal-title":"Biol Psychiatry."},{"key":"B26","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jaac.2016.07.767","article-title":"Intravenous immunoglobulin is not an effective treatment for pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection obsessive-compulsive disorder","volume":"55","author":"Mink","year":"2016","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"key":"B27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neurobiorev.2018.01.001","article-title":"Treatment of PANDAS and PANS: a systematic review","volume":"86","author":"Sigra","year":"2018","journal-title":"Neurosci Biobehav Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1089\/cap.2016.0148","article-title":"Clinical management of pediatric acute-onset neuropsychiatric syndrome: part II-use of immunomodulatory therapies","volume":"27","author":"Frankovich","year":"2017","journal-title":"J Child Adolesc Psychopharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1089\/cap.2020.0100","article-title":"Evaluation of intravenous immunoglobulin in pediatric acute-onset neuropsychiatric syndrome","volume":"31","author":"Melamed","year":"2021","journal-title":"J Child Adolesc Psychopharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1089\/cap.2014.0149","article-title":"A pilot trial of cognitive behavioral therapy augmentation of antibiotic treatment in youth with pediatric acute onset neuropsychiatric syndrome- related obsessive compulsive disorder","volume":"25","author":"Nadeau","year":"2015","journal-title":"J Child Adolesc Psychopharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1097\/01.chi.0000231973.43966.a0","article-title":"Cognitive-behavioral therapy for PANDAS-related obsessive-compulsive disorder: findings from a preliminary waitlist controlled open trial","volume":"45","author":"Storch","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"key":"B32","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1089\/cap.2016.0105","article-title":"A survey of pediatric acute-onset neuropsychiatric syndrome characteristics and course","volume":"27","author":"Calaprice","year":"2017","journal-title":"J Child Adolesc Psychopharmacol."},{"key":"B33","first-page":"132","article-title":"Certain eating disorders may be a neuropsychiatric manifestation of PANDAS: case report","volume":"16","author":"Calkin","year":"2007","journal-title":"J Can Acad Child Adolesc Psychiatry"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.741176\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T04:34:21Z","timestamp":1632803661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.741176\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,28]]},"references-count":33,"alternative-id":["10.3389\/fneur.2021.741176"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.741176","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,28]]},"article-number":"741176"}}